EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX)

CUSIP: 29842P105

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 6 signals
Share change
+341,323
SEC-reported price per share
$3.28
Number of holders
11
Value change
+$1,118,946
Number of buys
8
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
61,607,578

Security key

29842P105

Report period

Q1 2025

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SCOTIA CAPITAL INC.
Disclosed value leader
SCOTIA CAPITAL INC.
Comparable rows
9/9
Latest evidence
31 Dec 2024
13F Lead comparable stake: 2.3% Showing 1-6 of 9 holder rows.

Quick read

SCOTIA CAPITAL INC. leads the comparable SEC ownership view at 2.3%.

9 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SCOTIA CAPITAL INC.'s linked filing trail.
Comparable ownership Top 5
SCOTIA CAPITAL INC. 2.3%
ROYAL BANK OF CANADA 0.46%
BANK OF MONTREAL /CAN/ 0.09%
GOLDMAN SACHS GROUP INC 0.06%
UBS Group AG 0.05%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 9 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SCOTIA CAPITAL INC.
13F
Company
13F
2.3%
$4,259,277
1,391,719 shares
31 Dec 2024
ROYAL BANK OF CANADA
13F
Company
13F
0.46%
$898,000
283,145 shares
31 Dec 2024
BANK OF MONTREAL /CAN/
13F
Company
13F
0.09%
$177,824
56,750 shares
31 Dec 2024
GOLDMAN SACHS GROUP INC
13F
Company
13F
0.06%
$109,365
34,500 shares
31 Dec 2024
UBS Group AG
13F
Company
13F
0.05%
$88,760
28,000 shares
31 Dec 2024
RAYMOND JAMES FINANCIAL INC
13F
Company
13F
0.02%
$36,813
11,613 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
2,167,593
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
54
Q1 2025 holders
11
Holder diff
-43
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .